Szemészet, 2006 (143. évfolyam, 1-4. szám)

2006-06-01 / 2. szám

Szemészet

6. Greiner J.V, MundorfT., Dubiner H., Lonsdale J., Casey R., Parver /.., Kapik B.M., Shams N.B.K., Alberson M.B.: Efficacy and safety of ketotifen fumarate 0.025% int he conjunctival antigen challenge model of ocular allergic conjunctivitis. Am J Ophthalmol 2003; 136: 1097-1105.

7. Hammer H.: A szem allergiás betegségei. In: Petrányi Gy. és mtsai: Klinikai Immunológia. Medicina, Budapest, 2000; 369-371.

B. Horak F, Stübner P, Zieglmayer R., Kawina A., Moser M., Lanz R.: Onset and duration of action os ketotifen 0.025% and emedastine

0.05% in seasonal allergic conjunctivitis. Clin Drug Invest 2003; 23: 329-337.

9. ISAAC Steering Committee: Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctiviitis, and atopic eczema. Lancet 1998; 351: 1225-1232.

10. Kidd M., McKenzie S.H., Steven /., Cooper C., Lanz R.: Australian Ketotifen Study Group. Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis. Br J Ophthalmol 2003; 87: 1206-11.

11. Kinet J.P.: The high-affinity receptor for immunoglobulin-E: Structure, function and role in allergy: In Gallin J.I., Goldstein I.M., Snyderman R. (eds): Inflammation: basic principles and clinical correlates. 2nd ed. New York: Raven Press, 1992; 702-705.

12. McGill J.I., Holgate S.T., Church M.K., Bacon A.: Allergic eye disease mechanisms. Br J Ophthalmol 1998; 82: 1203-1214.

13. Schoch C.: Effects of ketotifen 0.025% and lodoxamide 0.1% on eosinophil infiltration into the guinea pig conjunctiva in a model of allergic conjunctivitis. J Ocul Pharmacol Ther 2003; 19: 153-9.

14. Woerly G„ Loiseau S., Loyens M., Schoch C, Capron M.: Inhibitory effects of ketotifen on eotaxin-dependent activation of eosinophils: consequences for allergic eye diseases. Allergy 2003; 58: 397-406.

15. Yanni J.M., Sharif N. A., Gamache D.A., Miller S.T., Weimer L.K., Spellman J.M.: A current appreciation of sites for pharmacological intervention in allergic conjunctivitis: effects of new topical ocular drugs. Acta Ophthalmol Scand 1999; 77: 33-37.

16 Hidasi V.: Az allergiás conjunctivitisek terápiája. Orvosi Hetilap 2000; 34: 1859-1865.

Levelezési cím: Dr. Tóth-Molnár Edit SZTE ÁOK, Szemészeti Klinika 6720 Szeged, Korányi fasor 10-11. E-mail: mailto:tme@invitel.hu

T